Do Analysts Expect Genocea Biosciences Inc (GNCA) Stock to Rise After It Is Lower By -16.30% in a Month?

Wednesday, December 29, 2021 09:50 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Genocea Biosciences Inc (GNCA) Stock to Rise After It Is Lower By -16.30% in a Month?

Analysts who follow Genocea Biosciences Inc (GNCA) on average expect it to gain 464.16% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns Genocea Biosciences Inc an Analyst Ranking of 74, which means it ranks higher than 74 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating GNCA a Strong Buy today. Find out what this means to you and get the rest of the rankings on GNCA!

See Full GNCA Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Genocea Biosciences Inc Stock Today?

Genocea Biosciences Inc (GNCA) stock is lower by -7.38% while the S&P 500 has gained 0.14% as of 9:49 AM on Wednesday, Dec 29. GNCA has fallen -$0.09 from the previous closing price of $1.22 on volume of 120,206 shares. Over the past year the S&P 500 is up 28.61% while GNCA has fallen -51.29%. GNCA lost -$0.58 per share the over the last 12 months. Click Here to get the full Stock Report for Genocea Biosciences Inc stock.